baito logo
    navigation?.buttons?.createJob?.text
    Fire
    new
    KyooBe Tech GmbH header
    KyooBe Tech GmbH logo
    #pharmatech #vaccineinnovation #cellgenetherapy

    KyooBe Tech GmbH

    from Leinfelden

    KyooBe Tech GmbH develops innovative technologies for the pharmaceutical industry, especially for vaccines and cell/gene therapies. The company is revolutionizing production with forward-looking solutions.

    Visit websiteArrowRight

    About KyooBe Tech GmbH

    Edit

    KyooBe Tech GmbH is an innovative company that focuses on the development of cutting-edge technological solutions for the pharmaceutical industry, particularly in the field of vaccine manufacturing as well as cell and gene therapy. As pioneers and bridge builders, KyooBe Tech combines interdisciplinary perspectives and different worlds to master biological challenges with technological innovations.

    The company's goal is to revolutionize the next generation of pharmaceutical production. KyooBe Tech develops innovative manufacturing platforms that aim to enable access to advanced therapeutic methods for a broader patient population. The focus is on improving production methods and capacities to pave the way for a healthier future.

    A core product of KyooBe Tech is the eFIT series, a revolutionary technology for inactivating pathogens. This technology is based on Low Energy Electron Irradiation (LEEI), which quickly and reliably destroys the genetic material of pathogens in liquid solutions. eFIT offers a chemical-free alternative to traditional inactivation methods and is characterized by rapid inactivation times, scalability and the absence of toxic chemicals. The eFIT Lab platform enables comprehensive feasibility studies and process optimizations in vaccine research and development as well as in contamination control.

    Another important project is MOSAIC, a flexible and modular platform for personalized cell and gene therapy. MOSAIC aims to automate and scale the production of complex individualized therapies to make them accessible to a broader market.

    KyooBe Tech benefits from a strategic partnership with Bausch+Ströbel SE + Co. KG, a world-leading supplier of filling and packaging systems for the pharmaceutical industry. This partnership enables KyooBe Tech to draw on over 30 years of experience and expertise in the field of GMP-compliant pharmaceutical systems.

    The company attaches great importance to an interdisciplinary approach and employs a highly motivated team of biotechnologists, IT experts, engineers and process engineers. KyooBe Tech sees itself as an agile and future-oriented company that is always striving to develop innovative solutions for the challenges of the pharmaceutical industry.

    By combining technological expertise and biological know-how, KyooBe Tech makes an important contribution to the development and manufacture of next-generation vaccines and cell and gene therapies. The company is committed to improving the efficiency, quality and safety of pharmaceutical processes and thus advancing healthcare worldwide.

    Quellen:

    Edit
    1. https://kyoobe.tech/
    2. https://kyoobe.tech/about-us/
    3. https://kyoobe.tech/vaccine-manufacturing/
    4. https://kyoobe.tech/inactivate-2/
    5. https://kyoobe.tech/research/leei-project/
    6. https://kyoobe.tech/about-us/bs-group/
    7. https://kyoobe.tech/mosaic/
    8. https://kyoobe.tech/vaccine-manufacturing-old/
    9. https://kyoobe.tech/gallery/